The DEAD-box RNA helicase 51 controls non-small cell lung cancer proliferation by regulating cell cycle progression via multiple pathways.

Author Information (click to view)

Wang X, Liu H, Zhao C, Li W, Xu H, Chen Y,

Wang X, Liu H, Zhao C, Li W, Xu H, Chen Y, (click to view)

Wang X, Liu H, Zhao C, Li W, Xu H, Chen Y,

Share on FacebookTweet about this on TwitterShare on LinkedIn

Scientific reports 2016 05 206() 26108 doi 10.1038/srep26108


The genetic regulation of cell cycle progression and cell proliferation plays a role in the growth of non-small cell lung cancer (NSCLC), one of the most common causes of cancer-related mortality. Although DEAD-box RNA helicases are known to play a role in cancer development, including lung cancer, the potential involvement of the novel family member DDX51 has not yet been investigated. In the current study we assessed the role of DDX51 in NSCLC using a siRNA-based approach. DDX51 siRNA-expressing cells exhibited a slower cell proliferation rate and underwent arrest in S-phase of the cell cycle compared with control cells. Microarray analyses revealed that DDX51siRNA expression resulted in the dysregulation of a number of cell signalling pathways. Moreover, injection of DDX51 siRNA into an animal model resulted in the formation of smaller tumours compared with the control group. We also assessed the expression of DDX51 in patients with NSCLC, and the data revealed that the expression was correlated with patient age but no other risk factors. Overall, our data suggest for the first time that DDX51 aids cell cancer proliferation by regulating multiple signalling pathways, and that this protein might be a therapeutic target for NSCLC.

Submit a Comment

Your email address will not be published. Required fields are marked *

18 − 7 =